Persistent Asset Partners »

Unicycive Therapeutics shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Unicycive Therapeutics (UNCY) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Unicycive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Unicycive Therapeutics held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Unicycive Therapeutics by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $177k 27k 6.58

More positions owned by Persistent Asset Partners

Viking Therapeutics Call Option (VKTX)
Kodiak Sciences Call Option (KOD)
Corning Incorporated Call Option (GLW)
Eyepoint Com New Call Option (EYPT)
Corbus Pharmaceuticals Hldgs Com New Call Option (CRBP)
Capricor Therapeutics Com New Call Option (CAPR)
United Therapeutics Corporation Call Option (UTHR)
Lumentum Hldgs (LITE)
Sandisk Corp Put Option (SNDK)
Voyager Therapeutics Call Option (VYGR)
Axt (AXTI)
Vaxcyte Call Option (PCVX)
Intel Corporation (INTC)
Tower Semiconductor Shs New (TSEM)
Edgewise Therapeutics Call Option (EWTX)

View all positions for Persistent Asset Partners

Top funds holding Unicycive Therapeutics

Vivo Capital
Millennium Management
Octagon Capital Advisors
Nantahala Capital Management
Vanguard Capital Management
Dr. Jeffrey R. Jay, M.D.
Vanguard Group
Logos Global Management
Citadel Advisors
Geode Capital Management
Morgan Stanley
Jane Street
Dimensional Fund Advisors
Bnp Paribas Arbitrage, Snc
Vanguard Fiduciary Trust

View all funds holding Unicycive Therapeutics